Christina Kim is a seasoned business development executive with extensive experience in the life sciences industry. Currently serving as Vice President of Business Development at Samsung Biologics since 2023, Christina has held previous leadership roles, including Vice President of Business Development and M&A at Danaher Corporation from 2020 to 2022, and Vice President of Strategy & Portfolio at Ortho Clinical Diagnostics from 2015 to 2020. Earlier career achievements include serving as LS Divisional Vice President of Strategy & Business Development at Merck Millipore and a focus on sales, marketing, and business development at Gentek Inc. Christina holds a Bachelor of Science degree in Chemical Engineering from Cornell University and an MBA in Marketing from St. John's University, The Peter J. Tobin College of Business.
This person is not in any teams
This person is not in any offices